April 27, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma Sees Opportunities Resulting from AACR Conference Attendance and Presentation
April 22, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma, Inc. Engages Charles River Laboratories to Initiate FDA-Requested Study to Support Initiation of HemaXellerate Clinical Trial
April 16, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma Recruits Renowned Cancer Stem Cell Experts to Scientific Advisory Board
April 13, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma Narrows Selection of CRO Candidates for HemaXellerate GLP Safety Studies Requested by the FDA
April 9, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma Inc. Announces Small Molecule Drug Discovery Milestones at the American Association for Cancer Research’s 2015 Annual Meeting
April 7, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma Inc. to Present Multiple Presentations at the 13th International Symposium on Myelodysplastic Syndromes
April 6, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma Expands Its Differentiation Therapy of Cancer Stem Cells Platform With Filing of Patent Applications on Silencing of NR2F2
April 1, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma CEO Discusses Recent Financings, New Laboratory Facilities and Preferred Stock Dividend
March 31, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma Announces Presentation of DiffronC at Cold Spring Harbor Conference on RNA & Oligonucleotide Therapeutics
March 24, 2015 | SOURCE: REGEN BIOPHARMA, INC.
Regen BioPharma, Inc. Expands Research Capacity With New Laboratory Facilities